Silybum marianum(milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia
- 29 February 2012
- journal article
- case report
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 18 (3), 360-365
- https://doi.org/10.1177/1078155212438252
Abstract
Hepatotoxicity has been observed with several chemotherapy agents and combination regimens. Conventional treatment methods often include supportive care or observation. We report a case of a patient with noted transaminitis presumed secondary to chemotherapy, which did not resolve with supportive care but was shown to respond to milk thistle. The patient had an immediate decrease in liver function tests and showed decreased elevation in levels upon treatment with subsequent chemotherapy regimens. This case demonstrates the potential efficacy of milk thistle as a unique hepatoprotective agent.Keywords
This publication has 16 references indexed in Scilit:
- A randomized, controlled, double‐blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)Cancer, 2009
- Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion responseInvestigational New Drugs, 2009
- Drug–drug interactions of silymarin on the perspective of pharmacokineticsJournal of Ethnopharmacology, 2009
- Silymarin, the Antioxidant Component of Silybum marianum, Prevents Sepsis-Induced Acute Lung and Brain InjuryJournal of Surgical Research, 2008
- Silymarin Protects Against Liver Damage in BALB/c Mice Exposed to Fumonisin B1 Despite Increasing Accumulation of Free Sphingoid BasesToxicological Sciences, 2004
- Herbal Modulation of P‐GlycoproteinDrug Metabolism Reviews, 2004
- Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibininJournal of Hepatology, 1996
- Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjectsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990
- Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liverJournal of Hepatology, 1989
- Chemotherapy of Amanita phalloides Poisoning with Intravenous SilibininHuman Toxicology, 1983